Clinical Trial Update: PANK-003 Cell Injection Combined With Standard Adjuvant Chemotherapy After Surgery in Patients With Stage IIIA NSCLC [Phase 2]

View source ↗

Summary

Describes a Phase 2 trial of PANK-003 cell injection with standard adjuvant chemotherapy for stage IIIA non-small cell lung cancer, with the study currently not…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• PANK-003 Cell Injection (PANK-003)

Snippet

Sponsor: Shenzhen Celconta Life Science Co., Ltd. | Conditions: Stage IIIA Non-small Cell Lung Cancer | Phase 2 | Status: NOT_YET_RECRUITING